Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2
W Huang, Y Xing, L Zhu, J Zhuo, M Cai - Experimental Cell Research, 2021 - Elsevier
Sorafenib is a multi-kinase inhibitor that has been highlighted as a tumor suppressor due to
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2
W Huang, Y Xing, L Zhu, J Zhuo, M Cai - Experimental Cell Research, 2021 - inis.iaea.org
[en] Sorafenib is a multi-kinase inhibitor that has been highlighted as a tumor suppressor
due to its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
due to its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
W Huang, Y Xing, L Zhu, J Zhuo… - Experimental Cell …, 2021 - europepmc.org
Sorafenib is a multi-kinase inhibitor that has been highlighted as a tumor suppressor due to
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2
W Huang, Y Xing, L Zhu, J Zhuo, M Cai - Experimental Cell Research, 2021 - osti.gov
Sorafenib is a multi-kinase inhibitor that has been highlighted as a tumor suppressor due to
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2
W Huang, Y Xing, L Zhu, J Zhuo… - Experimental cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Sorafenib is a multi-kinase inhibitor that has been highlighted as a tumor suppressor due to
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …
its anti-proliferative and anti-angiogenic properties, whereas the clinical application of …